Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
Nystrom and Associates Ltd, located in Saint Paul, MN, provides a full spectrum of substance use care across multiple modalities such as intensive outpatient, standard outpatient, and medication-assisted treatment (methadone/buprenorphine or naltrexone). Their expertise lies in incorporating 12-step facilitation, anger management techniques, and brief intervention strategies. The center develops personalized treatment plans for young people, adult men, and adult women, catering to both adolescent and adult populations. Serving both male and female individuals, Nystrom and Associates Ltd is committed to delivering high-quality care within a nurturing setting. For those in search of successful addiction treatment that emphasizes customized services and unique program offerings, this organization is devoted to supporting your journey toward wellness.
Nystrom and Associates Ltd, located in Big Lake, MN, delivers extensive treatment options for substance use disorders for both adults and teenagers. The facility offers a variety of services including intensive outpatient programs, general outpatient care, and methadone/buprenorphine or naltrexone treatments. Emphasizing 12-step facilitation, anger management, and brief intervention strategies, the center serves adult men, adult women, and youths. Nystrom and Associates Ltd is known for its gender-specific approaches, providing individualized care plans for male and female clients. With its commitment to high-quality service and specialized programs, this center stands out as a significant support for those in need of effective and customized addiction treatment.
Nystrom and Associates Ltd, located in Big Lake, MN, provides an extensive variety of treatment options for individuals dealing with substance abuse and concomitant mental health disorders, catering to both adults and children. The center offers flexible choices, including long-term, short-term, and 24-hour residential care, designed to meet the unique requirements of each client. Employing methodologies such as 12-step support, anger management techniques, and brief intervention strategies, Nystrom and Associates Ltd formulates customized treatment plans. With a strong emphasis on personalizing care, the center ensures that each individual receives focused attention and support throughout their recovery journey. The center welcomes both males and females, creating an encouraging atmosphere for healing.
Nystrom and Associates Ltd, situated in Baxter, MN, provides a full spectrum of substance abuse recovery options. Their offerings include intensive outpatient care, general outpatient services, and medication-assisted treatment with methadone, buprenorphine, or naltrexone. Employing strategies such as 12-step facilitation, anger management techniques, and brief intervention, they support adolescents, adult men, and adult women. The facility welcomes both male and female patients of all ages, from children and adolescents to adults. Nystrom and Associates Ltd is dedicated to delivering high-quality, personalized addiction treatment.
Nystrom and Associates Ltd, located in Saint Paul, MN, specializes in providing comprehensive treatment for substance use disorders among both adults and teenagers. The center features various treatment modalities, including intensive outpatient programs, outpatient services, and options for methadone, buprenorphine, or naltrexone. Emphasizing 12-step approaches, anger management, and brief interventions, the facility designs its programs to address the unique needs of adult men, adult women, and adolescents. Nystrom and Associates Ltd is committed to offering exceptional care for those pursuing effective addiction recovery in a nurturing setting.
Nystrom and Associates Ltd located in Cambridge, MN, provides extensive treatment options for substance use, including intensive outpatient, outpatient, and programs utilizing methadone, buprenorphine, or naltrexone. The facility implements strategies such as 12-step facilitation, anger management, and brief intervention tailored for adult men and women, adolescents, and those impacted by intimate partner violence. With programs designed for different genders and age ranges, Nystrom and Associates Ltd focuses on personalized treatment to address varied challenges. Patients can anticipate high-quality, evidence-based care offered by a team of skilled professionals, making it a prominent option for individuals seeking compassionate and effective support in their recovery journey.
Nystrom and Associates Ltd, situated in Rochester, MN, provides a wide range of treatment options for substance use disorders for both adults and teenagers. The center features intensive outpatient programs, standard outpatient services, as well as specific outpatient treatments with methadone/buprenorphine or naltrexone. Emphasizing methods like 12-step support, anger management, and brief interventions, this facility serves adult men and women, along with adolescents. Nystrom and Associates Ltd develops customized treatment plans for every client, ensuring effective support for both genders. If you're looking for a nurturing setting for addiction recovery, this center is committed to guiding you toward sustained sobriety.
Nystrom and Associates Ltd, located in Eden Prairie, MN, delivers extensive addiction treatment services aimed at both adults and teenagers. This facility offers various programs, including intensive outpatient therapy, standard outpatient care, and targeted treatments with methadone/buprenorphine or naltrexone. Emphasizing techniques like 12-step support, anger management, and brief interventions, the center addresses the unique needs of adult men, adult women, and adolescents. Gender-specific programs ensure personalized approaches to care. Nystrom and Associates Ltd stands out for its commitment to providing high-quality addiction rehabilitation, making it a preferred option for those in search of effective and empathetic treatment in the Eden Prairie region.
Nystrom and Associates Ltd, located in Minneapolis, MN, provides a wide range of substance use treatment options along with tailored support for individuals facing both substance use issues and significant mental health challenges or emotional struggles. The facility features intensive outpatient programs, standard outpatient services, and specialized treatments using methadone, buprenorphine, or naltrexone. Emphasizing approaches such as 12-step support, brief intervention techniques, and cognitive behavioral therapy, this center serves adult males and females, including those who have suffered from intimate partner or domestic violence. Catering to both adults and children/adolescents, it also offers gender-specific programs. Patients can look forward to receiving exceptional, personalized treatment at this esteemed rehabilitation facility.
Situated in Hopkins, MN, Nystrom and Associates Ltd provides focused treatment for substance abuse among adults facing significant mental health challenges, alongside services for children dealing with severe emotional issues. The center features both intensive outpatient and outpatient programs, offering treatments like methadone/buprenorphine or naltrexone. With approaches including 12-step programs, anger management, and short interventions, the facility serves adult men and women, including those affected by intimate partner violence. Catering to both adult and child/adolescent clients, and offering gender-specific programs, Nystrom and Associates Ltd delivers holistic support in a nurturing setting.
Nystrom and Associates Ltd, located in Saint Paul, MN, provides an extensive range of substance use rehabilitation programs designed for adults, teenagers, and children. The center features intensive outpatient care, outpatient services, and specific therapies involving methadone, buprenorphine, or naltrexone. Emphasizing 12-step programs, anger management, and brief interventions, it serves both male and female participants. Tailored programs for adult men, adult women, and adolescents reinforce a personalized approach to treatment. Nystrom and Associates Ltd takes pride in offering high-quality, gender-sensitive rehabilitation to assist individuals on their journey toward recovery.
Situated in Osseo, MN, Nystrom and Associates Ltd delivers a wide range of treatment programs for substance use tailored to both adults and teenagers. The center features intensive outpatient programs, general outpatient services, as well as options for outpatient treatment using methadone/buprenorphine or naltrexone. Emphasizing 12-step methods, anger management techniques, and brief intervention strategies, this facility serves clients of all genders. Additionally, there are specialized programs designed for adolescents, adult males, and adult females. Known for its commitment to high-quality care and personalized treatment strategies, Nystrom and Associates Ltd is devoted to assisting individuals on their recovery journey.
Nystrom and Associates Ltd, located in Duluth, MN, delivers tailored recovery services for individuals across all age groups, including adults, teenagers, and younger persons. They provide comprehensive treatment tiers such as intensive outpatient services, general outpatient care, and medication-assisted treatment including methadone, buprenorphine, or naltrexone. Employing methodologies like 12-step encouragement, emotional regulation training, and brief counseling, the facility addresses the distinct requirements of adult males, adult females, and adolescents. Nystrom and Associates Ltd is committed to delivering effective support for those pursuing freedom from addiction. Their gender-affirming programs foster a secure and understanding atmosphere for both male and female participants as they work toward lasting abstinence.
Nystrom and Associates Ltd, situated in Minneapolis, MN, delivers a wide range of substance use recovery programs designed for both adults and teenagers. The facility features intensive outpatient care, various outpatient offerings, and treatment options involving methadone/buprenorphine or naltrexone. Emphasizing 12-step methods, anger management techniques, and brief interventions, the center serves adult men, adult women, and adolescents. Its targeted programs for distinct age groups and genders guarantee personalized support for each person. Nystrom and Associates Ltd is committed to providing effective, research-supported treatment to aid individuals in their recovery process.
Nystrom and Associates Ltd, located in Hutchinson, MN, provides comprehensive outpatient treatment for substance use disorders. Their services include intensive outpatient programs, general outpatient care, and medication-assisted treatment with methadone, buprenorphine, or naltrexone. The center utilizes therapeutic approaches such as 12-step facilitation, anger management, and brief interventions. Nystrom and Associates Ltd supports adolescents, adult men, and adult women, offering gender-specific programming for both male and female clients, as well as care for children and adolescents. They are dedicated to delivering personalized and effective care to aid individuals in achieving and maintaining sobriety.
Nystrom and Associates Ltd located in Alexandria, MN, provides a wide range of treatment options for those struggling with substance use. The facility features intensive outpatient services, standard outpatient programs, and specialized treatments with methadone/buprenorphine or naltrexone. Emphasizing a 12-step recovery model, anger management strategies, and brief intervention techniques, the center serves adolescents, adult males, and adult females. Catering to both adults and younger populations, it ensures tailored care for male and female clients alike. Nystrom and Associates Ltd in Alexandria is dedicated to offering personalized, high-quality support to help individuals navigate their recovery journey from addiction.
Nystrom and Associates Ltd, located in Fergus Falls, MN, provides individualized programs for substance use recovery. The center specializes in intensive outpatient services, standard outpatient support, and treatments utilizing methadone, buprenorphine, or naltrexone. Emphasizing 12-step principles, anger management, and concise intervention methods, the facility addresses the needs of adolescents as well as adult men and women. Catering to both adults and younger clients, it ensures that services are tailored to meet the specific needs of each gender. Nystrom and Associates Ltd is recognized for its diverse approach to treatment and a strong dedication to helping individuals on their journey to overcoming substance use challenges.
Situated in Bemidji, MN, Nystrom and Associates Ltd specializes in a wide range of substance abuse treatment options for both adults and teenagers. The facility features intensive outpatient programs, standard outpatient services, as well as outpatient treatment using methadone, buprenorphine, or naltrexone. With an emphasis on 12-step support, anger management, and brief intervention strategies, Nystrom and Associates Ltd customizes its treatment plans to address the unique requirements of each client. The center offers specific programs aimed at adolescents, adult men, and adult women. Nystrom and Associates Ltd fosters an inclusive and supportive atmosphere for all clients, regardless of gender. Discover exceptional care and individualized treatment at this esteemed rehabilitation facility.
Nystrom and Associates Ltd, located in Moorhead, MN, delivers targeted substance abuse recovery programs for both young people and adults. Their offerings include comprehensive outpatient services, intensive outpatient care, and medication-assisted treatment options like methadone, buprenorphine, or naltrexone. The center employs evidence-based strategies such as 12-step integration, anger management training, and brief intervention techniques, ensuring a personalized approach to each client's recovery path. Dedicated programs are provided for adolescents, adult men, and adult women. At Nystrom and Associates Ltd, individuals of all ages and genders receive dedicated support and effective treatment to aid their return to wellness.
Nystrom and Associates Ltd, located in Mankato, MN, provides extensive support for individuals struggling with substance misuse. They offer various levels of care, including intensive outpatient, outpatient, and medication-assisted treatment options like methadone, buprenorphine, or naltrexone. The center is particularly skilled in utilizing approaches such as 12-step facilitation, anger management techniques, and brief intervention strategies. Nystrom and Associates Ltd designs personalized treatment for adolescents, adult men, and adult women, accommodating a wide range of ages and genders. Their services extend to care for children and adolescents, ensuring that each person receives a treatment plan developed specifically for their needs. This dedication to high-quality care and specialized programming establishes Nystrom and Associates Ltd as a leading provider of effective and compassionate addiction recovery services.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.